wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q40846805-41474500-CAF1-4852-B95A-89D1373390E6
Q40846805-41474500-CAF1-4852-B95A-89D1373390E6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40846805-41474500-CAF1-4852-B95A-89D1373390E6
Concurrent sorafenib therapy extends the interval to subsequent TACE for patients with unresectable hepatocellular carcinoma.
P2860
Q40846805-41474500-CAF1-4852-B95A-89D1373390E6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40846805-41474500-CAF1-4852-B95A-89D1373390E6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
bdbac4b5ed724e799dd764b7accbc88e20ca1844
P2860
Comparative efficacy of sorafenib versus best supportive care in recurrent hepatocellular carcinoma after liver transplantation: a case-control study.